NCT00723307 Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study Status COMPLETED Phase PHASE4
NCT00722371 MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) Status COMPLETED Phase PHASE3
NCT00715624 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin Status COMPLETED Phase PHASE3
NCT00713830 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea Status COMPLETED Phase PHASE3
NCT00712673 GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin Status COMPLETED Phase PHASE3
NCT00708578 Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) Status COMPLETED Phase PHASE4
NCT00707031 GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin Status COMPLETED Phase PHASE3
NCT00700817 The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00699036 Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) Status UNKNOWN Phase PHASE2
NCT00698789 Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE2
NCT00698230 Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics Status COMPLETED Phase PHASE2
NCT00690456 Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT00683735 Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis Status COMPLETED Phase PHASE2/PHASE3
NCT00682890 Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS) Status TERMINATED Phase PHASE4
NCT00682448 Metformin for the Prevention of the Metabolic Side-effects of Zyprexa Status COMPLETED Phase PHASE4
NCT00679939 Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health Status COMPLETED Phase PHASE4